Peijia Medical

JenaValve Technology announced a strategic investment and exclusive technology licensing agreement with Peijia Medical Limited, granting Peijia exclusive rights to develop and commercialize JenaValve's Trilogy TAVR systems in Greater China, in exchange for cash, equity, and milestone payments.

Peijia Medical and HighLife SAS entered into a license agreement granting Peijia an exclusive license to manufacture, develop, and commercialize HighLife's TMVR products in Greater China, with upfront fee and milestone payments.